3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
27
Breast Neoplasms
23
Neoplasm Metastasis
14
Glioma
14
Carcinoma, Non-Small-Cell Lung
14
Lymphoma
12
Lung Neoplasms
11
Glioblastoma
11
Neuroblastoma
10
Lymphoma, Non-Hodgkin
9
Carcinoma, Renal Cell
9
Brain Neoplasms
9
Medulloblastoma
8
Ovarian Neoplasms
7
Neoplasms
7
Multiple Myeloma
7
Ependymoma
7
Carcinoma, Hepatocellular
7
Wilms Tumor
6
Thyroid Neoplasms
6
Sarcoma
6
Rectal Neoplasms
6
Pancreatic Neoplasms
6
Osteosarcoma
6
Melanoma
6
Fallopian Tube Neoplasms
6
Central Nervous System Neoplasms
6
Uterine Cervical Neoplasms
5
Urinary Bladder Neoplasms
5
Triple Negative Breast Neoplasms
5
Interventions
pembrolizumab
8
Nivolumab
5
avelumab
4
Ipilimumab
4
Radiotherapy
2
Radiosurgery
2
ALT-803
2
tremelimumab
1
talimogene laherparepvec
1
sapanisertib
1
prednylidene
1
poly ICLC
1
lenvatinib
1
interferon gamma-1b
1
epacadostat
1
efineptakin alfa
1
durvalumab
1
deltacortene
1
cemiplimab
1
cabozantinib
1
bempegaldesleukin
1
atezolizumab
1
Tacrolimus
1
Radiation Dose Hypofractionation
1
Radiation
1
Prednisone
1
Interferon-gamma
1
Interferon-beta
1
CTLA-4 Antigen
1
B7-H1 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Merkel Cell
×
Magnetic Resonance Spectroscopy
×
Clear all
No trials found.